Skip to content
Matrix Global Advisors
Matrix Global Advisors
  • Home
  • About
  • News
  • Our Work
  • Contact
  • Home
  • About
  • News
  • Our Work
  • Contact
Oct52018

MGA’s Alex Brill on CNBC’s Squawk Box

October 5, 2018Filed Under: Interviews

“We’ve seen three months of strong economic growth in the labor market and we are adding jobs. I’d also just add we are two weeks away of getting the state level numbers and I think that will be informative both with respect to the weather effects and quite frankly some of the political aspects. We will have a better insight as to where these jobs are being created.”

Details
Oct42018

The US labor market data is great. What does it mean for this year’s midterms?

October 4, 2018Filed Under: Op-Eds

Tomorrow, the American public will get a fresh glimpse at the state of the US labor market. The Bureau of Labor Statistics’ (BLS) release of the September employment report, which will be the next-to-last before the upcoming election, will provide voters new insight on job growth and unemployment rates.

Details
Sep82018

Alex Brill Presents at GRx+Biosims 2018 Conference

September 8, 2018Filed Under: Events

As Brill sees it, there are 4 main categories of barriers to biosimilar uptake: reference product manufacturers, biosimilar manufacturers, policy, and education.

Details
Sep62018

New MGA Paper Identifies Steps to Reducing Barriers to Biosimilars

September 6, 2018Filed Under: Analysis

In a new paper, MGA discusses why the biosimilars market in the United States is not more developed and what steps can be taken to boost competition for biologic drugs. The paper identifies barriers to biosimilars by four categories, related to reference product manufacturers, biosimilar manufacturers, policy, and stakeholder education and awareness. Among the strategies to overcoming barriers are more physician and patient education, competitive biosimilar pricing, action by employer-sponsored health plans and private payors to encourage biosimilar utilization, and continued FDA efforts to support the budding market.

Details
Sep52018

New MGA Study Estimates Lost Savings from Misuse of REMS and Restricted Access Programs

September 5, 2018Filed Under: Analysis

A new study from MGA examines the practice by brand drug manufacturers of using Risk Evaluation and Mitigation Strategies (REMS) and other forms of restricted access to keep generic manufacturers from obtaining samples needed to develop generic drugs. MGA estimates that this misuse blocks $13.4 billion in generic savings annually, an estimate that has grown nearly 250 percent since MGA’s 2014 analysis of this issue.

Details
Aug182018

MGA’a Alex Brill on WXTK’s ‘Something More with Chris Boyd’

August 18, 2018Filed Under: Interviews

In the ‘Something More with Chris Boyd’ interview, Brill discusses the state of the economy.

Details
Aug72018

Happy Birthday, FDA Tobacco Plan!

August 7, 2018Filed Under: Op-Eds

Just over a year ago, the Food and Drug Administration (FDA) announced a bold new plan to reduce nicotine in cigarettes to non-addictive levels and encourage the development of non-combustible nicotine products. Key to the FDA’s approach is an acknowledgement of both the continuum of risks associated with various nicotine delivery mechanisms and the opportunity for innovative products to reduce the health risks associated with tobacco consumption

Details
Jul92018

MGA’s Alex Brill on CNBC’s Squawk Box

July 9, 2018Filed Under: Interviews

“…. There are specific issues with regards to our trade relationship with China. But not only with China, with other of our major trading partners around the world. We are better off with good intellectual property laws. We are better off with lower tariff and non-tariff barriers. We need a process that takes us from where we are forward and not backwards, of course.”

Details
Jul62018

MGA’s Alex Brill on White House Chronicle

July 6, 2018Filed Under: Interviews

Brill said, “If we take a market-based approach, which we think is a conservative strategy to addressing climate change, we want to use price signals, and a carbon tax is a price signal. It negates the need for…the regulatory toolbox that’s currently being deployed…and allows the market to find…the most efficient way to get emissions down.”

Details
Jun262018

Supreme Court Ruling on Online Sales Tax Sets Level Playing Field

June 26, 2018Filed Under: Op-Eds

The Supreme Court’s 5-4 ruling in South Dakota v. Wayfair last weekempowers states to establish a level playing field for the taxation of goods sold by in-state and out-of-state sellers. The court overturned two precedents, dating back to 1967 and 1992, that imposed an artificial physical presence rule on state sales tax systems.

Details
1
2345
…678910…
111213141516171819
20
  • Analysis(27)
  • Books(2)
  • Events(13)
  • Interviews(33)
  • News(43)
  • Op-Eds(59)
  • Press Releases(2)
  • Testimony(18)
  • Almost-Speaker McCarthy
    November 23, 2020
  • Nursing Homes Prepare for Third COVID-19 Surge
    October 26, 2020
  • Impact of the Coronavirus Pandemic on Red, Blue, and Swing States
    October 20, 2020
  • Trump Roils Markets with Conflicting Statements on Pandemic Relief
    October 7, 2020

Website Design and Developed by DreamBig Creative